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ABSTRACT
Background: Immunomodulators such as lipopolysaccharides (LPS) and forskolin change the nature of den-
dritic cells (DCs) to induce Th1 and Th2 cells, respectively, thereby designated Th1 or Th2 adjuvants. Our pre-
vious study showed that such activities can be qualitatively evaluated by expression patterns of Notch ligand
isoforms, using human monocyte-derived DCs and some leukemic cell lines, such as THP-1 or KG-1. However,
quantitative evaluation of the adjuvant activities was not fully established.
Methods: PMA-treated human monocytic cell line THP-1 was used as a target. Cells were stimulated with
various adjuvants, and the intracellular levels of cAMP were determined.
Results: Th2 adjuvant forskolin was qualitatively evaluated by an increased expression of Delta1 in PMA-
treated THP-1 cells, as reported in our previous study. In PMA-treated THP-1 cells, intracellular cAMP levels in-
creased after stimulation with forskolin, in a dose-dependent manner. On the other hand, LPS, one of the
known Th1 adjuvants, suppressed the increased cAMP level in a dose-dependent manner.
Conclusions: Th2- and Th1-adjuvant activities can be quantitatively evaluated by using PMA-treated THP-1
cells and PMA-treatedforskolin-stimulated THP-1 cells, respectively.
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INTRODUCTION
Dendritic cells (DCs) play a pivotal role in the differ-
entiation of naïve CD4 T helper cells toward Th1 or
Th2 cells. Environmental molecules, such as LPS,
certain nucleic acids and fungus-derived glycoprotein
molecules alter the DC function and induce Th1 dif-
ferentiation.1 Because such DCs induce Th1 re-
sponses, they are designated DC1, and DC1-inducing
molecules are called Th1 adjuvants. DC2 and Th2 ad-
juvants have also been reported. DCs matured in the
presence of forskolin or prostaglandin E2 (PGE2) in-
duce the differentiation of naïve CD4 T cells toward
Th2.2 Moreover, induction of DC2 by PGE2 was asso-
ciated with increased intracellular cAMP levels.3
Notch signaling pathways are highly conserved in
organisms ranging from invertebrates to mammals
and they are involved in cell fate choice during devel-
opment.4 We have reported, by using human sys-
tems, a correlation of Notch ligand mRNA levels of
monocyte-derived DCs (Mo-DCs) and leukemic
APCs with Th1Th2 adjuvant activities.5 Increased
expression of Delta1 and Delta4 mRNA on DCs can
predict Th2 and Th1 adjuvant activities, respectively.
Indeed, in other studies using mouse models, Notch
was directly regulated to Gata-3 expression during
Th2 differentiation.6,7 In this study, by using human
THP-1 cells, we quantitatively evaluated Th1Th2 ad-
juvant activities.
METHODS
CELL
THP-1 cells were cultured in RPMI1640 media, sup-
plemented with 10% fetal calf serum, 1% penicillin and
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Fig. 1 Delta1 expression levels were evaluated by using 
PMA-treated THP-1 cels. Cels were either mock-stimulated 
or adjuvant-stimulated for 3 hours, and subjected to RT-
PCR analysis.
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streptomycin, and 1% L-glutamine in a humidified in-
cubator under 5% CO2 at 37℃.
RT-PCR ANALYSIS OF NOTCH LIGAND GENE
EXPRESSION
THP-1 cells were treated with 50 ngml phorbol 12-
myristate 13-acetate (PMA) for 48 hours. PMA-
treated THP-1 cells were washed and then stimulated
with either 1 μgml LPS from Escherichia coli (Sigma,
Japan, Cat. No. L2143) as a Th1 adjuvant or 5μM
forskolin as a Th2 adjuvant for 3 hours, followed by
extraction of total RNA using TRIzol Reagent (Invitro-
gen Life Technologies, Carlsbad, CA). The obtained
total RNA was subjected to cDNA synthesis by the
SuperScript II RnaseH− reverse transcriptase (Invitro-
gen Life Technologies) using oligo (dT) primers. β-
actin gene transcripts were amplified as internal con-
trols. The sense and antisense primers specific for
Delta1 and β-actin genes were designed as described
previously.5
MEASUREMENT OF INTRACELLULAR cAMP
THP-1 cells exposed to increasing dose of PMA, were
washed and then incubated at 37℃ in the presence of
1 mM 3-isobutyl-1-methyl-xantine. Ten minutes later,
the cells were stimulated with increasing doses of
forskolin for 10 minutes, and then were lysed with
cell lysis buffer (Molecular Devices). In some experi-
ments, THP-1 cells treated with 50 ngml PMA for 48
hours, were exposed to 5 μM forskolin and or in-
creasing doses of LPS. Intracellular cAMP levels
were determined using the CatchPointTM cyclic-
AMP fluorescent assay kit (Molecular Devices), ac-
cording to the manufacturer’s instructions.
RESULTS
To determine whether a Th2 adjuvant forskolin ex-
hibits Delta1-inducing activity, we observed Delta1
mRNA expression by using RT-PCR. As expected,
forskolin but not LPS induced increased Delta1
mRNA expression on PMA-treated THP-1 cells (Fig.
1). Because LPS induced increased Delta4 expres-
sion in our previous study,5 such differential induc-
tion of Notch ligand isoforms can be used for a quali-
tative evaluation of Th1Th2 adjuvants. However,
quantitative evaluation of the activities requires real-
time RT-PCR analysis, which is not suitable for a
high-throughput assay. We therefore tried to use in-
tracellular cAMP levels for the high-throughput as-
say, which have been reportedly to be increased by
Th2 adjuvants.3
As shown in Figure 2, mock-treated (PMA 0
ngml) THP-1 cells did not exhibit forskolin-induced
cAMP elevation. In PMA-treated THP-1 cells, cAMP
elevation was observed in a forskolin dose-dependent
manner. It is noteworthy that at 50 ngml PMA, 5 μM
forskolin most markedly induced cAMP elevation.
Similar results were obtained from studies using
PMA-derived KG-1 cells. However, cAMP elevation of
KG-1 cells induced by forskolin was marginal. We
therefore used PMA-treated THP-1 cells in the subse-
quent studies. The viability of THP-1 cells markedly
decreased at 50―100 ngml PMA in the presence of
10 μM forskolin. Such forskolin-induced cAMP eleva-
tion at 50 ngml PMA can be used as target cells for
Th1 adjuvants. Thus, as shown in Figure 3, PMA (50
ngml)-treated and forskolin (5 μM)-induced cAMP
elevation was inhibited by LPS, in a dose-dependent
manner, ranging from 0.01 to 10 μgml of LPS. The
data was shown as mean value of duplicate determi-
nations.
LPS and forskolin are known to be Th1 and Th2 ad-
juvants, respectively. Indeed, we have demonstrated
that LPS and forskolin antagonized each other, by us-
ing MLR systems (data not shown). In the present
study, forskolin dose-dependently induced intracellu-
lar cAMP levels in PMA-treated THP-cells. Further-
more, Delta1 mRNA expression was increased in a
forskolin-dose-dependent manner (data not shown),
which is indicative of the availability for the quantita-
tive and qualitative evaluation of Th2 adjuvant activi-
ties. The forskolin-induced cAMP elevation was suc-
cessfully antagonized by LPS, again in a dose-
dependent manner, which is indicative of the avail-
ability for the quantitative evaluation of the Th1 adju-
vant activity.
In Vitro Evaluation of Adjuvants
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Fig. 2 THP-1 cels were incubated with 0, 10, 50 and 100 ng/ml of PMA. Forty-eight 
hours later, cels were washed, and then exposed to increasing doses of forskolin. Intracel-
lular cAMP levels were determined using the CatchPointTM cyclic-AMP fluorescent assay 
kit, as described in“Methods”.
0
1
2.5
5
PMA 0 ng/ml PMA 10 ng/ml PMA 50 ng/ml PMA 100 ng/ml 
Forskolin μM 0 2.5 5 10 0 2.5 5 10 0 2.5 5 10 0 2.5 5 10
cAMP nM
THP-1 cells
Fig. 3 THP-1 cels were treated with 50 ng/ml PMA. Forty-eight hours 
later, cels were washed, and then exposed to combinations of 5 μM forsko-
lin and increasing doses of LPS. Intracelular cAMP levels were determined 
using the CatchPointTM cyclic-AMP fluorescent assay kit, as described in
“Methods”.
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DISCUSSION
The detection of Th1Th2 adjuvant activities has long
been dependent on an assay for the cytokine profiles
induced on T cells by co-culturing with APCs stimu-
lated with adjuvants.8 This assay requires a large
amount of labor and more than 2 weeks due to the
preparation of cells from healthy donors and a large
number of culture processes. In addition, the hetero-
geneities of cell sources and donor-to-donor variances
may also lead to difficulties in obtaining stable and re-
producible results. The present study demonstrated
for the first time that measurement of intracellular
cAMP in PMA-derived THP-1 cells have the potential
to scrutinize and evaluate Th1Th2 adjuvant candi-
dates out of a large number of environmental sub-
stances and natural products, without possible insta-
bility arising from cell sources and polymorphisms. It
is also of note that this assay system can be used for
the evaluation of live bacteria, because 3-hour incuba-
tion with live probiotic bacteria did not decrease the
viability of THP-1 cells and successfully induced
Delta1 and Delta4.5
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